Steel Peak Wealth Management LLC Alnylam Pharmaceuticals, Inc. Transaction History
Steel Peak Wealth Management LLC
- $2.25 Billion
- Q3 2024
A detailed history of Steel Peak Wealth Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Steel Peak Wealth Management LLC holds 2,475 shares of ALNY stock, worth $610,830. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,475
Previous 3,546
30.2%
Holding current value
$610,830
Previous $861,000
21.02%
% of portfolio
0.03%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding ALNY
# of Institutions
642Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$4.07 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.12 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.36 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.29 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.22 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...